by Robert Korngold, PhD
This member spotlight features ex-officio ASTCT Board member Dr. Robert Korngold Ph.D., editor-in-chief for the Transplantation and Cellular Therapy journal. Korngold, a retired research scientist...
by Clinical Cancer Research
Chimeric antigen receptor (CAR) T-cell treatment has had limited success against pancreatic ductal adenocarcinoma (PDAC), but there is hope that incorporating ibrutinib or PD-1 blockade might...
by Journal of Clinical Investigation
Scientists developed a conditioning protocol that, followed by allogeneic bone marrow transplantation and islet transplantation, produces a favorable mix of host and donor hematopoietic stem cells...
by Blood
The results of a prospective study favor the use of a standardized protocol for allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with a particular type of B-cell...
by Bone Marrow Transplantation
Donor traits and graft sources have a role in how outcomes play out after haploidentical hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia (ALL), report members of a...
by ASTCT Talks
In this episode of ASTCT Talks, host Terri Lynn Shigle, PharmD (The University of Texas MD Anderson Cancer Center; Pharmacy SIG Immediate Past-Chair), sits down with Zainab Shahid, MD (Memorial...